Express Scripts Holding Co (ESRX) Shareholder Greatmark Investment Partners Boosted Its Stake by $5.07 Million; Bio Rad Labs (BIO) Stock Price Rose While Beaconlight Capital Has Cut Its Holding by $3.54 Million

April 26, 2018 - By Migdalia James

Bio-Rad Laboratories, Inc. (NYSE:BIO) Logo

Ed Bosek decreased its stake in Bio Rad Labs Inc (BIO) by 21.91% based on its latest 2017Q4 regulatory filing with the SEC. Beaconlight Capital Llc sold 14,869 shares as the company’s stock rose 2.21% while stock markets declined. The hedge fund run by Ed Bosek held 53,005 shares of the capital goods company at the end of 2017Q4, valued at $12.65M, down from 67,874 at the end of the previous reported quarter. Beaconlight Capital Llc who had been investing in Bio Rad Labs Inc for a number of months, seems to be less bullish one the $7.72 billion market cap company. The stock decreased 0.98% or $2.55 during the last trading session, reaching $258.93. About 121,590 shares traded. Bio-Rad Laboratories, Inc. (NYSE:BIO) has risen 25.02% since April 26, 2017 and is uptrending. It has outperformed by 13.47% the S&P500.

Greatmark Investment Partners Inc increased its stake in Express Scripts Holding Co (ESRX) by 17135% based on its latest 2017Q4 regulatory filing with the SEC. Greatmark Investment Partners Inc bought 68,540 shares as the company’s stock declined 5.58% with the market. The institutional investor held 68,940 shares of the medical and nursing services company at the end of 2017Q4, valued at $5.15 million, up from 400 at the end of the previous reported quarter. Greatmark Investment Partners Inc who had been investing in Express Scripts Holding Co for a number of months, seems to be bullish on the $43.29 billion market cap company. The stock increased 0.76% or $0.58 during the last trading session, reaching $77.1. About 921,592 shares traded. Express Scripts Holding Company (NASDAQ:ESRX) has risen 8.93% since April 26, 2017 and is uptrending. It has underperformed by 2.62% the S&P500.

Analysts await Bio-Rad Laboratories, Inc. (NYSE:BIO) to report earnings on May, 3. They expect $0.93 earnings per share, up 126.83% or $0.52 from last year’s $0.41 per share. BIO’s profit will be $27.74M for 69.60 P/E if the $0.93 EPS becomes a reality. After $1.50 actual earnings per share reported by Bio-Rad Laboratories, Inc. for the previous quarter, Wall Street now forecasts -38.00% negative EPS growth.

Investors sentiment increased to 1.13 in 2017 Q4. Its up 0.35, from 0.78 in 2017Q3. It improved, as 23 investors sold BIO shares while 89 reduced holdings. 44 funds opened positions while 82 raised stakes. 18.57 million shares or 0.31% more from 18.51 million shares in 2017Q3 were reported. Employees Retirement Sys Of Ohio reported 0.02% stake. Gamco Investors Et Al holds 46,762 shares. Menta Cap holds 2,502 shares. Earnest Prtn Limited Liability Corp holds 0.25% of its portfolio in Bio-Rad Laboratories, Inc. (NYSE:BIO) for 109,307 shares. Wealth Enhancement Advisory Services Ltd Com invested 0.02% of its portfolio in Bio-Rad Laboratories, Inc. (NYSE:BIO). Fifth Third Bancorp stated it has 4,232 shares or 0.01% of all its holdings. Pacad Investment, a British Columbia – Canada-based fund reported 1,000 shares. Castleark Llc reported 19,280 shares stake. Proshare Ltd Liability Co has invested 0% in Bio-Rad Laboratories, Inc. (NYSE:BIO). State Street invested in 0.01% or 550,442 shares. Sg Americas Secs Ltd Co invested in 0.02% or 9,883 shares. Employees Retirement Association Of Colorado invested 0.01% of its portfolio in Bio-Rad Laboratories, Inc. (NYSE:BIO). Lpl Financial Ltd Company has invested 0% in Bio-Rad Laboratories, Inc. (NYSE:BIO). Virginia Retirement Et Al owns 2,000 shares. Ubs Asset Management Americas stated it has 0.07% of its portfolio in Bio-Rad Laboratories, Inc. (NYSE:BIO).

Since December 14, 2017, it had 0 buys, and 1 insider sale for $1.24 million activity.

Among 5 analysts covering Bio-Rad Laboratories (NYSE:BIO), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Bio-Rad Laboratories had 20 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was downgraded by C.L. King on Friday, February 16 to “Hold”. The stock of Bio-Rad Laboratories, Inc. (NYSE:BIO) has “Buy” rating given on Wednesday, September 27 by Jefferies. The stock has “Buy” rating by Jefferies on Wednesday, April 12. Jefferies maintained Bio-Rad Laboratories, Inc. (NYSE:BIO) on Friday, October 20 with “Buy” rating. The firm earned “Buy” rating on Friday, April 28 by Jefferies. The rating was maintained by Jefferies on Thursday, July 13 with “Buy”. The firm has “Buy” rating given on Wednesday, June 28 by Deutsche Bank. The rating was initiated by CL King on Thursday, October 13 with “Buy”. The firm has “Buy” rating by Jefferies given on Wednesday, September 7. Wells Fargo maintained Bio-Rad Laboratories, Inc. (NYSE:BIO) on Tuesday, March 20 with “Buy” rating.

Greatmark Investment Partners Inc, which manages about $285.51 million and $275.91 million US Long portfolio, decreased its stake in Anthem Inc (NYSE:ANTM) by 1,387 shares to 16,852 shares, valued at $3.79 million in 2017Q4, according to the filing. It also reduced its holding in Microsoft Corp (NASDAQ:MSFT) by 7,891 shares in the quarter, leaving it with 155,038 shares, and cut its stake in Intel Corp (NASDAQ:INTC).

Investors sentiment increased to 0.69 in Q4 2017. Its up 0.07, from 0.62 in 2017Q3. It improved, as 68 investors sold ESRX shares while 407 reduced holdings. 111 funds opened positions while 216 raised stakes. 479.40 million shares or 1.52% less from 486.80 million shares in 2017Q3 were reported. Marshall & Sullivan Wa holds 40,997 shares or 2.45% of its portfolio. 35,690 were reported by Psagot House. Acropolis Investment Llc owns 3,800 shares. Bluestein R H & accumulated 0.02% or 5,000 shares. Covington Cap has invested 0.01% in Express Scripts Holding Company (NASDAQ:ESRX). American Century invested in 0.17% or 2.30M shares. New Mexico Educational Retirement Board owns 55,540 shares. United Capital Fincl Advisers Ltd Limited Liability Company accumulated 0.08% or 134,882 shares. New York Life Investment Mgmt Limited Liability Company holds 2.79% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX) for 539,194 shares. Nordea Invest Management accumulated 1.23% or 6.97 million shares. 4,176 were reported by Clear Harbor Asset Mgmt Ltd Liability. 162,224 are held by Brown Advisory. 13,240 were reported by Parallax Volatility Advisers Lp. Agf Invests stated it has 0.17% in Express Scripts Holding Company (NASDAQ:ESRX). Louisiana-based Price Cap Mgmt has invested 0.61% in Express Scripts Holding Company (NASDAQ:ESRX).

Express Scripts Holding Company (NASDAQ:ESRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts